Solid Biosciences Inc. SLDB Enterprise value

Enterprise value at other companies

Sarepta Therapeutics, Inc.SRPT

$1.52B-2.9%

BiogenBIIB

$38.17B+70.8%

Neurocrine BiosciencesNBIX

$13.41B+18.5%

InsmedINSM

$23.15B+19.3%

RegenxbioRGNX

$651.8M+51.8%

Dyne Therapeutics, Inc.DYN

$2.41B+228%

FAQ

What is Solid Biosciences Inc.'s enterprise value?

Solid Biosciences Inc. (SLDB) reported enterprise value of $844.27M in Q2 2026.

How has Solid Biosciences Inc.'s enterprise value changed year-over-year?

Solid Biosciences Inc.'s enterprise value increased by 224.2% year-over-year, from $260.46M to $844.27M.

What is the long-term trend for Solid Biosciences Inc.'s enterprise value?

Over 5 years (2020 to 2025), Solid Biosciences Inc.'s enterprise value has grown at a -10.2% compound annual growth rate (CAGR), from $686.66M to $400.67M.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.